Bain Capital Life Sciences Investors, LLC Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$591.3B
Holdings
11
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,281,307 | $196.6B | 33.25% | |
| 2 | ARQTARCUTIS BIOTHERAPEUTICS, INC. | 3,979,292 | $118.6B | 20.05% | |
| 3 | —DICERNA PHARMACEUTICALS INC | 4,080,237 | $75.0B | 12.68% | |
| 4 | —CONSTELLATION PHARMACEUTICALS INC. | 2,203,529 | $69.3B | 11.71% | |
| 5 | DVAXDYNAVAX TECHNOLOGIES CORP. | 8,730,707 | $30.8B | 5.21% | |
| 6 | REPLREPLIMUNE GROUP INC | 2,838,968 | $28.3B | 4.79% | |
| 7 | YB4PSAVARA INC | 5,128,593 | $23.0B | 3.89% | |
| 8 | ASNSUSDX4 PHARMACEUTICALS INC | 1,648,485 | $16.5B | 2.79% | |
| 9 | —MARINUS PHARMACEUTICALS INC | 5,942,735 | $12.1B | 2.04% | |
| 10 | —APTINYX INC | 5,558,425 | $12.0B | 2.03% | |
| 11 | SLDBSOLID BIOSCIENCES INC | 3,871,164 | $9.3B | 1.56% |